Research

Stories about Princeton research relevant to a corporate and foundation audience.

2021 Nobel laureate David MacMillan brings attention to the power of academic collaboration, with industry and across disciplines, to catalyze new ideas

Monday, Oct 11, 2021

by Jonathan Garaffa

On October 6, Professor David MacMillan became the first Princeton faculty member to be awarded a Nobel Prize in chemistry. In that whirlwind of a day, MacMillan brought focus to one of the strategies he sees as critical to advancing fundamental science: Collaboration. Not just with scientists in one’s own field. But with scientists from other disciplines and with industry.
Physicist Elliott Lieb wins the highest honor bestowed by the American Physical Society

Friday, Jan 7, 2022

by Liz Fuller-Wright, Office of Communications

Mathematical physicist Elliott Lieb has been selected to receive the 2022 APS Medal for Exceptional Achievement in Research for “major contributions to theoretical physics through obtaining exact solutions to important physical problems, which have impacted condensed matter physics, quantum information, statistical mechanics and atomic physics.”
The NSF I-Corps Northeast Hub has launched, and applications are now open for its inaugural innovation training program for researchers

Thursday, Jan 6, 2022

by Catherine Zandonella, Office of the Dean for Research
A.J. te Velthuis studies why some viruses are deadly while others are harmless

Thursday, Jan 6, 2022

by Liz Fuller-Wright, Office of Communications; Catherine Zandonella, Office of the Dean for Research

Viruses outnumber humans by about 400 trillion to one, and yet pandemics are rare. Why? Why do a few viruses inflict so much damage, when the vast majority are harmless or even helpful?

Those questions drive A.J. te Velthuis, a virologist who joined Princeton’s molecular biology faculty in January 2021.
Oral and gut microbes can inactivate an antidiabetic drug, Princeton scientists find

Tuesday, Dec 21, 2021

by Caitlin Sedwick for the Department of Molecular Biology

Acarbose is a commonly prescribed antidiabetic drug that helps control blood sugar levels by inhibiting human enzymes that break down complex carbohydrates. Now, new research from the laboratory of Princeton researcher Mohamed Donia demonstrates that some bacteria in the mouth and gut can inactivate acarbose and potentially affect the clinical performance of the drug and its impact on bacterial members of the human microbiome.
Making the switch to a net-zero mindset

Wednesday, Dec 15, 2021

by Denise Valenti, Office of Communications

Green technology holds the promise of significantly reducing carbon emissions and helping humanity to avoid the worst impacts of climate change. But without buy-in from individuals and groups — whether it’s building new habits and routines to conserve energy or galvanizing support to enact policies that will enable the transition to cleaner tech — progress is likely to occur far more slowly than what is needed.
Humble lizards offer surprising approach to engineering artificial lungs

Thursday, Dec 23, 2021

by Scott Lyon, Office of Engineering Communications

When it comes to studying lungs, humans take up all the air, but it turns out scientists have a lot to learn from lizards.
Priestley, Xu honored in Newsweek for invention of cost-efficient, solar-powered water filter

Friday, Dec 17, 2021

by Jonathan Garaffa

Rodney Priestley, vice dean for innovation and the Pomeroy and Betty Perry Smith Professor of Chemical and Biological Engineering, and Xiaohui Xu, a Presidential Postdoctoral Research Fellow, have been featured in Newsweek’s list of America’s Greatest Disruptors: Mind Blowers for their invention of a solar-powered water filter that could provide clean drinking water in areas with limited access to electricity.
Using light, researchers coax bacteria and yeast, usually competitors, to cooperate in producing chemicals

Thursday, Dec 2, 2021

by Molly A. Seltzer

Strains of microbes like yeast and E. coli can be engineered to produce useful chemicals and fuels, and can produce more fuel more efficiently by working together. The problem is that when grown together in co-cultures, the fastest-growing strain often outcompetes the others, causing the community to break down and stop chemical production. Now, Princeton researchers have discovered a new way to stabilize co-cultures of microbes using light.
New cancer therapy from Yibin Kang’s lab holds potential to switch off major cancer types without side effects

Monday, Nov 29, 2021

by Liz Fuller-Wright, Office of Communications

Imagine you could cure cancer by targeting one tiny gene. Imagine that same gene occurred in every major cancer, including breast, prostate, lung, liver and colon. Imagine that the gene is not essential for healthy activity, so you could attack it with few or no negative side effects.

Search form

Research

2021 Nobel laureate David MacMillan brings attention to the power of academic collaboration, with industry and across disciplines, to catalyze new ideas

Physicist Elliott Lieb wins the highest honor bestowed by the American Physical Society

The NSF I-Corps Northeast Hub has launched, and applications are now open for its inaugural innovation training program for researchers

A.J. te Velthuis studies why some viruses are deadly while others are harmless

Oral and gut microbes can inactivate an antidiabetic drug, Princeton scientists find

Making the switch to a net-zero mindset

Humble lizards offer surprising approach to engineering artificial lungs

Priestley, Xu honored in Newsweek for invention of cost-efficient, solar-powered water filter

Using light, researchers coax bacteria and yeast, usually competitors, to cooperate in producing chemicals

New cancer therapy from Yibin Kang’s lab holds potential to switch off major cancer types without side effects

Pages